517 related articles for article (PubMed ID: 10804094)
21. Hand eczema and long-term prognosis in atopic dermatitis.
Rystedt I
Acta Derm Venereol Suppl (Stockh); 1985; 117():1-59. PubMed ID: 2931938
[TBL] [Abstract][Full Text] [Related]
22. Safety and tolerability of ultra-rush induction, less than one hour, of sublingual immunotherapy in children.
Tripodi S; Di Rienzo Businco A; Benincori N; Scala G; Pingitore G
Int Arch Allergy Immunol; 2006; 139(2):149-52. PubMed ID: 16374025
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children.
Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J
Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
25. [New administration routes for immunotherapy].
Martorell Aragonés A
Allergol Immunopathol (Madr); 2000; 28(3):93-102. PubMed ID: 10867377
[TBL] [Abstract][Full Text] [Related]
26. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study.
Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A
Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076
[TBL] [Abstract][Full Text] [Related]
27. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
28. Double-blind, placebo-controlled study of sublingual immunotherapy in patients with latex-induced urticaria: a 12-month study.
Nettis E; Colanardi MC; Soccio AL; Marcandrea M; Pinto L; Ferrannini A; Tursi A; Vacca A
Br J Dermatol; 2007 Apr; 156(4):674-81. PubMed ID: 17493066
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of specific immunotherapy in the treatment of children and youngsters suffering from atopic dermatitis. Part I. Evaluation of clinical score].
Silny W; Czarnecka-Operacz M; Silny P
Wiad Lek; 2005; 58(1-2):47-55. PubMed ID: 15991553
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the antiinflammatory and clinical effects of sublingual immunotherapy with carbamylated allergoid in allergic asthma with or without rhinitis. A 12-month perspective randomized, controlled, trial.
La Grutta S; Arena A; D'Anneo WR; Gammeri E; Leonardi S; Trimarchi A; Platania D; La Rosa M
Eur Ann Allergy Clin Immunol; 2007 Feb; 39(2):40-4. PubMed ID: 17441414
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of canine regulatory T cell populations, serum interleukin-10 and allergen-specific IgE concentrations in healthy control dogs and canine atopic dermatitis patients receiving allergen-specific immunotherapy.
Keppel KE; Campbell KL; Zuckermann FA; Greeley EA; Schaeffer DJ; Husmann RJ
Vet Immunol Immunopathol; 2008 Jun; 123(3-4):337-44. PubMed ID: 18423890
[TBL] [Abstract][Full Text] [Related]
32. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
33. Clinical and immunologic effects of sublingual immunotherapy on patients with allergic rhinitis to house-dust mites: 1-year follow-up results.
Kim ST; Han DH; Moon IJ; Lee CH; Min YG; Rhee CS
Am J Rhinol Allergy; 2010; 24(4):271-5. PubMed ID: 20819465
[TBL] [Abstract][Full Text] [Related]
34. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
35. A 10-year open follow-up of eczema and respiratory symptoms in patients with atopic dermatitis treated with topical tacrolimus for the first 4 years.
Mandelin JM; Remitz A; Virtanen HM; Malmberg LP; Haahtela T; Reitamo S
J Dermatolog Treat; 2010 May; 21(3):167-70. PubMed ID: 20394492
[TBL] [Abstract][Full Text] [Related]
36. The safety of sublingual immunotherapy with one or multiple pollen allergens in children.
Agostinis F; Foglia C; Landi M; Cottini M; Lombardi C; Canonica GW; Passalacqua G
Allergy; 2008 Dec; 63(12):1637-9. PubMed ID: 19032238
[TBL] [Abstract][Full Text] [Related]
37. Dose dependence of immunological response to sublingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Incorvaia C; Frati F
Allergy; 2005 Jul; 60(7):952-6. PubMed ID: 15932387
[TBL] [Abstract][Full Text] [Related]
38. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
[TBL] [Abstract][Full Text] [Related]
39. Skin colonization by Staphylococcus aureus in patients with eczema and atopic dermatitis and relevant combined topical therapy: a double-blind multicentre randomized controlled trial.
Gong JQ; Lin L; Lin T; Hao F; Zeng FQ; Bi ZG; Yi D; Zhao B
Br J Dermatol; 2006 Oct; 155(4):680-7. PubMed ID: 16965415
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of allergen immunotherapy in the treatment of allergic rhinitis and asthma in real life.
Zeldin Y; Weiler Z; Magen E; Tiosano L; Kidon MI
Isr Med Assoc J; 2008 Dec; 10(12):869-72. PubMed ID: 19160945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]